Grants and Contributions:

Title:
Improvement of industrial production of gold and silver nanoparticles for life science applications
Agreement Number:
938124
Agreement Value:
$277,328.00
Agreement Date:
Nov 4, 2019 - Sep 17, 2021
Description:
In order to produce medical grade gold and silver nanoparticles, the firm must improve its current production and product quality control methods; the demand for very uniform and certified sterile nanoparticles, i.e. without biological contaminants (endotoxin free), is very important, especially by university research centres in hospitals. The project will allow the acquisition of new human and material resources necessary for the implementation of new processes, in order to achieve and certify that the products have the required purity.
Organization:
National Research Council Canada
Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:
Montreal, Quebec, CA H4S 2A4
Reference Number:
172-2019-2020-Q3-938124
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
807617212
Recipient Type:
For-profit organization
Additional Information:

This agreement has been amended 1 time(s). The total amended value is 17,868 dollars.

Amendment Date
Mar 24, 2021
Recipient's Operating Name:
SONO KEMIA
Recipient's Legal Name:
9220-3553 Québec inc.
Federal Riding Name:
Saint-Laurent
Federal Riding Number:
24068
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325189
Amendments: